Researchers work on imaging cancer patients' responses to drugs

10/6/2009 | AsiaOne News

Researchers at the Singapore Bioimaging Consortium's nuclear imaging group are exploring ways to image how drugs are working in cancer patients. They are studying various radioactive markers used in PET and PET/CT imaging, including thymidine tagged with a radioactive fluorine marker. Researchers also are developing a new imaging technique that uses terahertz radiation, a type of radiation that falls between infrared light and microwaves.

View Full Article in:

AsiaOne News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY